Pharmaceutical and therapeutic applications of artificial cells including microencapsulation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 45, Issue 1, 1998, Pages 3-8

  Chang, Thomas Ming Swi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Artificial cells; Cross linked hemoglobin; Microencapsulation; Nanocapsules

Indexed keywords

ACTIVATED CARBON; DRUG VEHICLE; ENZYME; HEMOGLOBIN; NANOCAPSULE; PHENYLALANINE AMMONIA LYASE; XANTHINE OXIDASE;

ARTIFICIAL MEMBRANE; CROSS LINKING; DRUG DELIVERY SYSTEM; HUMAN; INTOXICATION; KIDNEY FAILURE; LESCH NYHAN SYNDROME; LIVER FAILURE; MICROENCAPSULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHENYLKETONURIA; RAT; REVIEW;

EID: 0031837260     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00117-3     Document Type: Article

References (52)

1. T.M.S. Chang, Hemoglobin corpuscles. Research Report for Honours Physiology, Medical Library, McGill University, 1957. (Also reprinted as part of 30th anniversary in Artificial Red Blood Cells Research, J. Biomater. Artif. Cells Artif. Organs 16 (1988) 1-9.).
2. T.M.S. Chang, Hemoglobin corpuscles. Research Report for Honours Physiology, Medical Library, McGill University, 1957. (Also reprinted as part of 30th anniversary in Artificial Red Blood Cells Research, J. Biomater. Artif. Cells Artif. Organs 16 (1988) 1-9.).
3. Chang T.M.S. Semipermeable microcapsules. Science. 146:1964;524-525.
4. T.M.S. Chang, Semipermeable aqueous microcapsules. Ph.D. Thesis, McGill University, 1965.
5. Chang T.M.S., MacIntosh F.C., Mason S.G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 44:1966;115-128.
6. Chang T.M.S. Semipermeable aqueous microcapsules 'artificial cells': with emphasis on experiments in an extracorporeal shunt system. Trans. Am. Soc. Artif. Intern. Organs. 12:1966;13-19.
7. Chang T.M.S. Lipid-ocated spherical ultrathin membranes of polymer or cross-linked protein as possible cell membrane models. Fed. Proc. 28:1969;461.
8. T.M.S. Chang, Artificial Cells, Thomas, Springfield, IL, 1972.
9. T.M.S. Chang, F.C. MacIntosh, S.G. Mason, Encapsulated hydrophillic compositions and methods of making them, Canadian Patent, No. 873 815, 1971.
10. F. Gregoriadis, Liposomes as Drug Carriers: Recent Trends and Progress, Wiley, New York, 1989.
11. Chang T.M.S. Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biological. J. Bioeng. 1:1976;25-32.
12. Jalil R., Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microspheres. J. Microencapsulation. 7:1990;297.
13. E. Mathiowitz, R. Langer, Polyanhydride microspheres as drug delivery systems, in: M. Donbrow (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacology, CRC Press, Boca Raton, FL, 1992, pp. 99-123.
14. Chang T.M.S. Removal of endogenous and exogenous toxins by a microencapsulated absorbent. Can. J. Physiol. Pharmacol. 47(12):1969;1043-1045.
15. Chang T.M.S. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int. 7:1975;S387-S392.
16. Chang T.M.S. Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure. Kidney Int. 10:1976;S305-S311.
17. J.F. Winchester, Hemoperfusion, in: J. Maher (ed) Replacement of Renal Function by Dialysis, 3rd ed., Kluwer, Boston, MA 1988, pp. 439-460.
18. T.M.S. Chang, Biotechnology of artificial cells including application to artificial organs, in: M. Moo-Young, (Ed.), Comprehensive Biotechnology: The Principles, applications and Regulations of Biotechnology in Industry Agriculture and Medicine, Pergamon, New York, 1985, pp. 53-72.
19. T.M.S. Chang, R. Geyer (Eds.), Blood Substitutes, Marcel Dekker, New York, 1989, p. 714.
20. T.M.S. Chang, J. Reiss, R. Winslow (Eds.), Blood Substitutes (special issue), Artif. Cells Blood Substit. Immbolization Biotechnol., 22 (1994) 123-360.
21. T.M.S. Chang, G. Greenberg, E. Tsuchida, (Eds.), Blood Substitutes (special issue), Artif. Cells Blood Substit. Immbolization Biotechnol., 25 (1997) 1-227.
22. T.M.S. Chang, Blood Substitutes: Methods, Principles, Products and Clinical Trials, vol. 1., Karger/Landes Systems, Georgetown, TX, 1997.
23. Chang T.M.S. Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes. Artif. Cells, Blood Substit. Immobilization Biotechnol. 25:1997;1-24.
24. Chang T.M.S., Poznansky M.J. Semipermeable microcapsules containing catalase for enzyme replacement in acatalasemic mice. Nature. 218(5138):1968;242-245.
25. Poznansky M.J., Chang T.M.S. Comparison of the enzyme kinetics and immunological properties of catalase immobilized by microencapsulation and catalase in free solution for enzyme replacement. Biochim. Biophys. Acta. 334:1974;103-115.
26. Chang T.M.S. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature. 229(528):1971;117-118.
27. Chang T.M.S. Preparation and characterization of xanthine oxidase immobilized by microencapsulation in artificial cells for the removal of hypoxanthine. Biomater. Artif. Cells Artif. Organs. 17:1989;611-616.
28. Palmour R.M., Goodyer P., Reade T., Chang T.M.S. Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan disease. Lancet. 2(8664):1989;687-688.
29. Bourget L., Chang T.M.S. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuria rat model. Biochim. Biophys. Acta. 883:1986;432-438.
30. Chang T.M.S., Lister C. Plasma/Intestinal concentration patterns suggestive of entero-portal recirculation of amino acids: Effects of oral administration of asparaginase, glutaminase and tyrosinase immobilized by microencapsulation in artificial cells. Biomater. Artif. Cells Artif. Organs. 16:1988;915-926.
31. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-909.
32. Soon-Shiong P., Heintz R.E., Merideth N., Yao Q.X., Yao Z., Zheng T., Murphy M., Moloney M.K., Schmehll M., Harris M., Mendez R., Sandford P.A. Insulin independence in a type I diabetic patient after encapsulated islet transplantation. Lancet. 343:1994;950-951.
33. Wong H., Chang T.M.S. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif. Organs. 9:1986;335-336.
34. Bruni S., Chang T.M.S. Hepatocytes immobilized by microencapsulation in artificial cells: Effects on hyperbilirubinemia in Gunn rats. J. Biomater. Artif. Cells Artif. Org. 17:1989;403-412.
35. S. Bruni, T.M.S. Chang, Kinetic analysis of UDP-glycoronosyl-transferase in bilirubin conjugation by encapsulated hepatocytes for transplantation into rats, Artif. Org. 1995 19 (1995) 449-457.
36. Dixit V., Arthur M., Gitnick G. Repeated transplantation of microencapsulated hepatocytes for sustained correction of hyperbilirubinemia in Gunn rats. Cell Transplant. 1:1992;275-279.
37. R. Lanza, R. Langer, W.L. Chick, Principles of Tissue Engineering. Academic Press/Landes, Austin, TX, 1997.
38. W. Stevenson, M.V. Sefton, Development of polyacrylate microcapsules, in: M.F.A. Goosen (Ed.), Fundamentals of Animal Cell Encapsulation and Immobilization, CRC Press, Boca Raton, FL, 1993, pp. 143-182.
39. M.F.A. Goosen (Ed.), Fundamentals of Animal Cell Encapsulation and Immobilization, CRC Press Boca Raton, FL, 1993, pp. 326-362.
40. D. Poncelet, B. Poncelet, C. Beaulieu, R.J. Neufeld, Scale-up of gel bead and microcapsule production in cell immobilization, in: M.F.A. Goosen (Ed.), Fundamentals of Animal Cell Encapsulation and Immobilization, CRC Press, Boca Raton, FL, 1993, pp. 113-182.
41. Koo J., Chang T.M.S. Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int. J. Artif. Organs. 16:1993;557-560.
42. Wong H., Chang T.M.S. A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. Biomater. Artif. Cells Immobilization Biotechnol. 19:1991;687-698.
43. T.M.S. Chang, S. Prakash, Artificial cells for bioencapsulation of cells and genetically engineered E. coli: for cell therapy, gene therapy and removal of urea and ammonia. chap. 75 in: Expression and Detection of Recombinant Genes, in: Methods in Molecular Biology Series, Humana Press, Clifton, NJ, 1997, pp. 343-358.
44. Prakash S., Chang T.M.S. Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal. Biotechnol. Bioeng. 46:1995;621-626.
45. Prakahs S., Chang T.M.S. Microencapsulated genetically engineered live E coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2:1996;883-887.
46. Chang T.M.S. Live E. coli cells to treat uremia: replies to letters to the editor. Nat. Med. 3:1997;2-4.
47. T.M.S. Chang, Artificial cells, in: R. Dulbecco (Ed.), Encyclopedia of Human Biology vol. 1, Academic Press, San Diego, CA, 1991 pp. 377-383.
48. T.M.S. Chang, Recent advances in artificial cells with emphasis on biotechnological and medical approaches based on microencapsulation. in: M. Donbrow (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacology, CRC Press, Boca Raton, FL, 1992, pp. 323-339.
49. M. Donbrow (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacology, CRC Press, Boca Raton FL, 1992, pp. 323-339.
50. Chang T.M.S. Artificial cells with emphasis on bioencapsuolation in biotechnology. Biotechnol. Annu. Rev. 1:1995;267-296.
51. T.M.S. Chang (Ed.), Artificial Cells, Blood Substitutes and Immobilization Biotechnology, an international journal, Marcel Dekker, New York.
52. International Society for Artificial Cells, Blood Substitutes and Immobilization Biotechnology, Web site: www.physio.mcgill.ca/artcell.